The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy.

[1]  R. Gearry,et al.  Anti-TNFα Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series. , 2021, Inflammatory bowel diseases.

[2]  M. Kamm,et al.  459 CROHN'S DISEASE STRICTURES RESPOND TO DRUG TREATMENT AND TREAT-TO-TARGET INTENSE COMBINATION THERAPY IS MORE EFFECTIVE THAN STANDARD ANTI-TNF THERAPY. THE STRIDENT RANDOMISED CONTROLLED TRIAL. , 2021 .

[3]  M. Long,et al.  Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry , 2021, Gut.

[4]  M. Kamm,et al.  Efficacy of drug and endoscopic treatment of Crohn's disease strictures: A systematic review , 2020, Journal of gastroenterology and hepatology.

[5]  L. Dieleman,et al.  Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease , 2020, Digestive Diseases and Sciences.

[6]  R. Bryant,et al.  Monitoring Inflammatory Bowel Disease in Pregnancy using Gastrointestinal Ultrasonography. , 2020, Journal of Crohn's & colitis.

[7]  A. Amiot,et al.  Surgery for Crohn’s disease during pregnancy: A nationwide survey , 2020, United European gastroenterology journal.

[8]  N. Narula,et al.  Enteral nutritional therapy for induction of remission in Crohn's disease. , 2018, The Cochrane database of systematic reviews.

[9]  M. Vatn,et al.  Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study , 2017, Inflammatory bowel diseases.

[10]  Alys Einion.  The management of nausea and vomiting of pregnancy and hyperemesis gravidarum. , 2016, The practising midwife.

[11]  A. Bitton,et al.  The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. , 2016, Gastroenterology.